Global Glucagon Market Research Report 2022
Table of Contents1 Glucagon Market Overview
1.1 Product Overview and Scope of Glucagon
1.2 Glucagon Segment by Type
1.2.1 Global Glucagon Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Segment by Application
1.3.1 Global Glucagon Sales Comparison by Application: (2022-2028)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Size Estimates and Forecasts
1.4.1 Global Glucagon Revenue 2017-2028
1.4.2 Global Glucagon Sales 2017-2028
1.4.3 Glucagon Market Size by Region: 2017 Versus 2021 Versus 2028
2 Glucagon Market Competition by Manufacturers
2.1 Global Glucagon Sales Market Share by Manufacturers (2017-2022)
2.2 Global Glucagon Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Glucagon Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Glucagon Manufacturing Sites, Area Served, Product Type
2.5 Glucagon Market Competitive Situation and Trends
2.5.1 Glucagon Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Glucagon Players Market Share by Revenue
2.5.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucagon Retrospective Market Scenario by Region
3.1 Global Glucagon Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Glucagon Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Glucagon Market Facts & Figures by Country
3.3.1 North America Glucagon Sales by Country
3.3.2 North America Glucagon Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Glucagon Market Facts & Figures by Country
3.4.1 Europe Glucagon Sales by Country
3.4.2 Europe Glucagon Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Glucagon Market Facts & Figures by Region
3.5.1 Asia Pacific Glucagon Sales by Region
3.5.2 Asia Pacific Glucagon Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Glucagon Market Facts & Figures by Country
3.6.1 Latin America Glucagon Sales by Country
3.6.2 Latin America Glucagon Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Glucagon Market Facts & Figures by Country
3.7.1 Middle East and Africa Glucagon Sales by Country
3.7.2 Middle East and Africa Glucagon Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Glucagon Historic Market Analysis by Type
4.1 Global Glucagon Sales Market Share by Type (2017-2022)
4.2 Global Glucagon Revenue Market Share by Type (2017-2022)
4.3 Global Glucagon Price by Type (2017-2022)
5 Global Glucagon Historic Market Analysis by Application
5.1 Global Glucagon Sales Market Share by Application (2017-2022)
5.2 Global Glucagon Revenue Market Share by Application (2017-2022)
5.3 Global Glucagon Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Novo Nordisk Glucagon Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lilly Glucagon Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Fresenius Kabi Glucagon Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Torrent Labs
6.4.1 Torrent Labs Corporation Information
6.4.2 Torrent Labs Description and Business Overview
6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Torrent Labs Glucagon Product Portfolio
6.4.5 Torrent Labs Recent Developments/Updates
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Corporation Information
6.5.2 Taj Pharmaceuticals Description and Business Overview
6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
6.5.5 Taj Pharmaceuticals Recent Developments/Updates
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Corporation Information
6.6.2 Xeris Pharmaceuticals Description and Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments/Updates
7 Glucagon Manufacturing Cost Analysis
7.1 Glucagon Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Glucagon
7.4 Glucagon Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Glucagon Distributors List
8.3 Glucagon Customers
9 Glucagon Market Dynamics
9.1 Glucagon Industry Trends
9.2 Glucagon Market Drivers
9.3 Glucagon Market Challenges
9.4 Glucagon Market Restraints
10 Global Market Forecast
10.1 Glucagon Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Glucagon by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Glucagon by Type (2023-2028)
10.2 Glucagon Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Glucagon by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Glucagon by Application (2023-2028)
10.3 Glucagon Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Glucagon by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Glucagon by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Glucagon Sales Growth Rate Comparison by Type (2022-2028) & (K MT) & (US$ Million)
Table 2. Global Glucagon Sales Growth Rate Comparison by Application (2022-2028) & (K MT) & (US$ Million)
Table 3. Global Glucagon Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Glucagon Market Competitive Situation by Manufacturers in 2021
Table 5. Global Glucagon Sales (K MT) of Key Manufacturers (2017-2022)
Table 6. Global Glucagon Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Glucagon Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Glucagon Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Glucagon Average Price (USD/MT) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Glucagon Manufacturing Sites and Area Served
Table 11. Manufacturers Glucagon Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Glucagon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Glucagon Sales by Region (2017-2022) & (K MT)
Table 16. Global Glucagon Sales Market Share by Region (2017-2022)
Table 17. Global Glucagon Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Glucagon Revenue Market Share by Region (2017-2022)
Table 19. North America Glucagon Sales by Country (2017-2022) & (K MT)
Table 20. North America Glucagon Sales Market Share by Country (2017-2022)
Table 21. North America Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Glucagon Revenue Market Share by Country (2017-2022)
Table 23. Europe Glucagon Sales by Country (2017-2022) & (K MT)
Table 24. Europe Glucagon Sales Market Share by Country (2017-2022)
Table 25. Europe Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Glucagon Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Glucagon Sales by Region (2017-2022) & (K MT)
Table 28. Asia Pacific Glucagon Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Glucagon Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Glucagon Revenue Market Share by Region (2017-2022)
Table 31. Latin America Glucagon Sales by Country (2017-2022) & (K MT)
Table 32. Latin America Glucagon Sales Market Share by Country (2017-2022)
Table 33. Latin America Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Glucagon Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Glucagon Sales by Country (2017-2022) & (K MT)
Table 36. Middle East and Africa Glucagon Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Glucagon Revenue Market Share by Country (2017-2022)
Table 39. Global Glucagon Sales by Type (2017-2022) & (K MT)
Table 40. Global Glucagon Sales Market Share by Type (2017-2022)
Table 41. Global Glucagon Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Glucagon Revenue Share by Type (2017-2022)
Table 43. Global Glucagon Price by Type (2017-2022) & (USD/MT)
Table 44. Global Glucagon Sales (K MT) by Application (2017-2022)
Table 45. Global Glucagon Sales Market Share by Application (2017-2022)
Table 46. Global Glucagon Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Glucagon Revenue Share by Application (2017-2022)
Table 48. Global Glucagon Price by Application (2017-2022) & (USD/MT)
Table 49. Novo Nordisk Corporation Information
Table 50. Novo Nordisk Description and Business Overview
Table 51. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 52. Novo Nordisk Glucagon Product
Table 53. Novo Nordisk Recent Developments/Updates
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Description and Business Overview
Table 56. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 57. Eli Lilly Glucagon Product
Table 58. Eli Lilly Recent Developments/Updates
Table 59. Fresenius Kabi Corporation Information
Table 60. Fresenius Kabi Description and Business Overview
Table 61. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 62. Fresenius Kabi Glucagon Product
Table 63. Fresenius Kabi Recent Developments/Updates
Table 64. Torrent Labs Corporation Information
Table 65. Torrent Labs Description and Business Overview
Table 66. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 67. Torrent Labs Glucagon Product
Table 68. Torrent Labs Recent Developments/Updates
Table 69. Taj Pharmaceuticals Corporation Information
Table 70. Taj Pharmaceuticals Description and Business Overview
Table 71. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 72. Taj Pharmaceuticals Glucagon Product
Table 73. Taj Pharmaceuticals Recent Developments/Updates
Table 74. Xeris Pharmaceuticals Corporation Information
Table 75. Xeris Pharmaceuticals Description and Business Overview
Table 76. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 77. Xeris Pharmaceuticals Glucagon Product
Table 78. Xeris Pharmaceuticals Recent Developments/Updates
Table 79. Production Base and Market Concentration Rate of Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Glucagon Distributors List
Table 82. Glucagon Customers List
Table 83. Glucagon Market Trends
Table 84. Glucagon Market Drivers
Table 85. Glucagon Market Challenges
Table 86. Glucagon Market Restraints
Table 87. Global Glucagon Sales Forecast by Type (2023-2028) & (K MT)
Table 88. Global Glucagon Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Glucagon Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 90. Global Glucagon Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Glucagon Sales Forecast by Application (2023-2028) & (K MT)
Table 92. Global Glucagon Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Glucagon Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 94. Global Glucagon Revenue Market Share Forecast by Application (2023-2028)
Table 95. Global Glucagon Sales Forecast by Region (2023-2028) & (K MT)
Table 96. Global Glucagon Sales Market Share Forecast by Region (2023-2028)
Table 97. Global Glucagon Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 98. Global Glucagon Revenue Market Share Forecast by Region (2023-2028)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Glucagon
Figure 2. Global Glucagon Market Share by Type in 2021 & 2028
Figure 3. Inject Glucagon Product Picture
Figure 4. Nasal Glucagon Product Picture
Figure 5. Global Glucagon Market Share by Application in 2021 & 2028
Figure 6. Emergency Kits
Figure 7. General Use
Figure 8. Diagnostic & Motility
Figure 9. Cardiogenic Shock
Figure 10. Others
Figure 11. Global Glucagon Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Glucagon Market Size (2017-2028) & (US$ Million)
Figure 13. Global Glucagon Sales (2017-2028) & (K MT)
Figure 14. Glucagon Sales Share by Manufacturers in 2021
Figure 15. Global Glucagon Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Glucagon Players: Market Share by Revenue in 2021
Figure 17. Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Glucagon Sales Market Share by Region (2017-2022)
Figure 19. Global Glucagon Sales Market Share by Region in 2021
Figure 20. Global Glucagon Revenue Market Share by Region (2017-2022)
Figure 21. Global Glucagon Revenue Market Share by Region in 2021
Figure 22. U.S. Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Glucagon Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Glucagon by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Glucagon
Figure 46. Manufacturing Process Analysis of Glucagon
Figure 47. Glucagon Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed